M. Yamauchi

发表

Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, The Journal of clinical endocrinology and metabolism.

Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.

S. Mohan, K. Chihara, S. Yano, 2002, European journal of endocrinology.

[Osteoporosis in patients with diabetes mellitus].

M. Yamauchi, 2007, Nihon rinsho. Japanese journal of clinical medicine.

Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid

T. Sugimoto, Toru Yamaguchi, M. Yamauchi, 2010, Osteoporosis International.

Glucocorticoid Excess Affects Cortical Bone Geometry in Premenopausal, but not Postmenopausal, Women

K. Chihara, T. Sugimoto, M. Yamauchi, 2008, Calcified Tissue International.

The threshold of bone mineral density for vertebral fracture in female patients with glucocorticoid-induced osteoporosis.

K. Chihara, T. Sugimoto, M. Yamauchi, 2006, Endocrine journal.

The extracellular calcium Ca2+o-sensing receptor is expressed in myeloma cells and modulates cell proliferation.

K. Anderson, E. Brown, K. Chihara, 2002, Biochemical and biophysical research communications.

Determinants of vertebral fragility: the participation of cortical bone factors

K. Chihara, T. Sugimoto, M. Yamauchi, 2004, Journal of Bone and Mineral Metabolism.

Serum Levels of Insulin-Like Growth Factor (IGF); IGF-Binding Proteins-3, -4, and -5; and Their Relationships to Bone Mineral Density and the Risk of Vertebral Fractures in Postmenopausal Women

S. Mohan, K. Chihara, H. Kaji, 2006, Calcified Tissue International.

Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients with Type 2 Diabetes

T. Sugimoto, Toru Yamaguchi, Masahiro Yamamoto, 2010, Diabetes Care.

Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese postmenopausal women.

T. Shigematsu, T. Sugimoto, Toru Yamaguchi, 2010, The Journal of clinical endocrinology and metabolism.

Long-term efficacy and safety of vildagliptin add-on therapy in type 2 diabetes mellitus with insulin treatment.

I. Kanazawa, Ken-ichiro Tanaka, M. Notsu, 2017, Diabetes research and clinical practice.

Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitus.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, The Journal of clinical endocrinology and metabolism.

1 Long-term Efficacy and Safety of Vildagliptin Add-on Therapy in Type 2 Diabetes Mellitus Treatment with Insulin Running title : Vildagliptin with insulin therapy

I. Kanazawa, Ken-ichiro Tanaka, M. Notsu, 2016 .

Thyroid crisis caused by metastatic thyroid cancer: an autopsy case report

R. Maruyama, M. Notsu, Masahiro Yamamoto, 2021, BMC Endocrine Disorders.

Relationship between Endogenous Parathyroid Hormone and Bone Metabolism/Geometry in Female Patients Treated with Glucocorticoid

K. Chihara, T. Sugimoto, M. Yamauchi, 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Effects of age, grip strength and smoking on forearm volumetric bone mineral density and bone geometry by peripheral quantitative computed tomography: comparisons between female and male.

K. Chihara, T. Sugimoto, M. Yamauchi, 2005, Endocrine journal.

The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.

K. Chihara, T. Sugimoto, M. Yamauchi, 2005, European journal of endocrinology.

Body composition and vertebral fracture risk in female patients treated with glucocorticoid

K. Chihara, H. Kaji, T. Sugimoto, 2005, Osteoporosis International.

Determinants of Bone Mineral Density and Spinal Fracture Risk in Postmenopausal Japanese Women

K. Chihara, S. Yano, T. Sugimoto, 2001, Osteoporosis International.

Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women

K. Chihara, S. Yano, T. Sugimoto, 2001, Clinical endocrinology.

Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects.

K. Chihara, H. Sowa, T. Sugimoto, 2003, The Journal of clinical endocrinology and metabolism.

Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma

M. Notsu, Masahiro Yamamoto, M. Yamauchi, 2022, Internal medicine.

Another potential use of troglitazone in noninsulin-dependent diabetes mellitus.

M. Yamauchi, H. Koshiyama, J. Minamikawa, 1998, The Journal of clinical endocrinology and metabolism.

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

S. Yano, I. Kanazawa, T. Sugimoto, 2010, Osteoporosis International.

Phenylacetic Acid Stimulates Reactive Oxygen Species Generation and Tumor Necrosis Factor‐α Secretion in Vascular Endothelial Cells

S. Yano, T. Sugimoto, Toru Yamaguchi, 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.

S. Yano, I. Kanazawa, T. Sugimoto, 2008, Biochemical and biophysical research communications.

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement.

I. Endo, Hiroyuki Tanaka, Toshio Matsumoto, 2008, Bone.

Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes.

S. Tanaka, M. Yamauchi, H. Koshiyama, 1998, The Journal of clinical endocrinology and metabolism.

Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells

S. Yano, I. Kanazawa, T. Sugimoto, 2007, BMC Cell Biology.

Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes.

S. Yano, I. Kanazawa, T. Sugimoto, 2011, Bone.

A case of insulin-like growth factor 2-producing gastrointestinal stromal tumor with severe hypoglycemia

S. Ishihara, M. Notsu, Hiroki Sonoyama, 2020, BMC Endocrine Disorders.

Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus

I. Kanazawa, T. Sugimoto, M. Yamauchi, 2013, Osteoporosis International.

Bone Mineral Density Is not Sensitive Enough to Assess the Risk of Vertebral Fractures in Type 2 Diabetic Women

T. Sugimoto, Masahiro Yamamoto, M. Yamauchi, 2007, Calcified Tissue International.

Baseline atherosclerosis parameter could assess the risk of bone loss during pioglitazone treatment in type 2 diabetes mellitus

S. Yano, I. Kanazawa, T. Sugimoto, 2010, Osteoporosis International.

T. Sugimoto, M. Yamauchi, 2015, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

Trial to predict malignancy of affected parathyroid glands in primary hyperparathyroidism.

K. Chihara, H. Sowa, T. Sugimoto, 2003, Endocrine journal.

Low Bone Klinefelter Therapy Mineral Density Syndrome: Rapi in a Case of Mosaicism d Response to Testosterone

M. Yamauchi, H. Koshiyama, J. Minamikawa, 2006 .

Low bone mineral density in a case of mosaicism Klinefelter syndrome: rapid response to testosterone therapy.

M. Yamauchi, H. Koshiyama, J. Minamikawa, 1998, Endocrine journal.

Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia.

T. Fujita, T. Sugimoto, S. Fukumoto, 2009, Bone.

Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, American journal of physiology. Endocrinology and metabolism.

Association of polymorphic alleles of the calcium‐sensing receptor gene with the clinical severity of primary hyperparathyroidism

K. Chihara, S. Yano, T. Sugimoto, 2001, Clinical endocrinology.

Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report

Ayumu Takeno, I. Kanazawa, T. Sugimoto, 2019, BMC Endocrine Disorders.

Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment.

I. Endo, Toshio Matsumoto, K. Ozono, 2015, Endocrine journal.

Osteosarcoma in a pregnant patient with McCune-Albright syndrome.

R. Kitazawa, S. Yano, R. Maruyama, 2009, Bone.

Hypercalcemia associated with eosinophilic myocarditis in a patient undergoing maintenance hemodialysis.

K. Tanabe, S. Yano, Ken-ichiro Tanaka, 2012, Internal medicine.

Acute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone

S. Yano, T. Sugimoto, Toru Yamaguchi, 2011, Journal of Bone and Mineral Metabolism.

Rosuvastatin increased serum osteocalcin levels independent of its serum cholesterol-lowering effect in patients with type 2 diabetes and hypercholesterolemia.

I. Kanazawa, T. Sugimoto, Toru Yamaguchi, 2009, Internal medicine.

Short title: Osteocalcin and Atherosclerosis

S. Yano, I. Kanazawa, T. Sugimoto, 2008 .

Fasudil hydrochloride induces osteoblastic differentiation of stromal cell lines, C3H10T1/2 and ST2, via bone morphogenetic protein-2 expression.

S. Yano, I. Kanazawa, T. Sugimoto, 2010, Endocrine journal.

BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, Biochemical and biophysical research communications.

A case of magnesium deficiency associated with insufficient parathyroid hormone action and severe osteoporosis.

S. Yano, I. Kanazawa, T. Sugimoto, 2007, Endocrine journal.

Association of n-3 Polyunsaturated Fatty Acid Intake with Bone Mineral Density in Postmenopausal Women

T. Sugimoto, Toru Yamaguchi, M. Yamauchi, 2013, Calcified Tissue International.

Atypical ulnar fracture with atypical femoral fracture: A case report and literature review.

T. Ozaki, N. Yamamoto, T. Noda, 2020, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.

S. Yano, T. Sugimoto, Toru Yamaguchi, 2008, The Journal of clinical endocrinology and metabolism.

Improved peripheral cortical bone geometry after surgical treatment of primary hyperparathyroidism in postmenopausal women.

T. Sugimoto, M. Yamauchi, H. Kaji, 2008, The Journal of clinical endocrinology and metabolism.

Familial Hypocalciuric Hypercalcemia Caused by an R648stop Mutation in the Calcium‐Sensing Receptor Gene

E. Brown, K. Chihara, S. Yano, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Osteomalacia caused by atypical renal tubular acidosis with vitamin D deficiency: a case report

E. Sohara, Takayasu Mori, M. Notsu, 2021, CEN Case Reports.

The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs.

S. Yano, T. Sugimoto, Toru Yamaguchi, 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: Potential therapeutic targets for glucocorticoid-induced osteoporosis

S. Yano, I. Kanazawa, T. Sugimoto, 2009 .

Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells.

K. Chihara, T. Sugimoto, Toru Yamaguchi, 2005, American journal of physiology. Endocrinology and metabolism.

The Calcium-sensing Receptor (CaR) is Involved in Strontium Ranelate-induced Osteoblast Differentiation and Mineralization

S. Yano, T. Sugimoto, Toru Yamaguchi, 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Relationships between undercarboxylated osteocalcin and vitamin K intakes, bone turnover, and bone mineral density in healthy women.

T. Sugimoto, Toru Yamaguchi, M. Yamauchi, 2010, Clinical nutrition.

Plasma lipids and osteoporosis in postmenopausal women.

Toru Yamaguchi, Kazuo Chihara, K. Chihara, 2002, Endocrine journal.

Graves’ disease and vertebral fracture: Possible pathogenic link in postmenopausal women

M. Notsu, T. Sugimoto, M. Yamauchi, 2020, Clinical endocrinology.

The Presence and Severity of Vertebral Fractures is Associated with the Presence of Esophageal Hiatal Hernia in Postmenopausal Women

K. Chihara, S. Yano, T. Sugimoto, 2002, Osteoporosis International.

A case of ectopic thyroid in lateral neck associated with Graves' disease.

M. Yamauchi, K. Kakudo, H. Koshiyama, 1999, Endocrine journal.

Serum Osteocalcin/Bone-Specific Alkaline Phosphatase Ratio Is a Predictor for the Presence of Vertebral Fractures in Men with Type 2 Diabetes

S. Yano, I. Kanazawa, T. Sugimoto, 2009, Calcified Tissue International.

Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six‐year longitudinal study with or without parathyroidectomy in a Japanese population

K. Chihara, H. Sowa, T. Sugimoto, 2004, Clinical endocrinology.

Two-year longitudinal changes in forearm cortical bone geometry in postmenopausal women with mild primary hyperparathyroidism without parathyroidectomy.

M. Yamauchi, H. Kaji, R. Nomura, 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

A pregnant woman with an autonomously functioning thyroid nodule: a case report

M. Notsu, T. Sugimoto, M. Yamauchi, 2020, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Causes and differential diagnosis of hypocalcemia--recommendation proposed by expert panel supported by ministry of health, labour and welfare, Japan.

I. Endo, Hiroyuki Tanaka, Toshio Matsumoto, 2008, Endocrine journal.

Primary Aldosteronism as a Risk Factor for Vertebral Fracture

M. Notsu, T. Sugimoto, Masahiro Yamamoto, 2017, The Journal of clinical endocrinology and metabolism.

Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitus.

S. Yano, I. Kanazawa, T. Sugimoto, 2008, Endocrine journal.

[The Importance of teriparatide in the treatment of osteoporosis].

M. Yamauchi, 2016, Clinical calcium.

Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.

T. Sugimoto, Masahiro Yamamoto, M. Yamauchi, 2013, The Journal of clinical endocrinology and metabolism.

Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.

S. Yano, I. Kanazawa, T. Sugimoto, 2008, European journal of endocrinology.

T. Sugimoto, Toru Yamaguchi, Masahiro Yamamoto, 2009, Diabetes Care.

Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications

T. Sugimoto, Toru Yamaguchi, Masahiro Yamamoto, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.

S. Yano, I. Kanazawa, T. Sugimoto, 2009, Bone.

Functional giant parathyroid cyst with high concentration of CA19-9 in cystic fluid.

R. Kitazawa, K. Chihara, H. Sowa, 2003, Endocrine journal.

Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women

Ken-ichiro Tanaka, T. Sugimoto, Toru Yamaguchi, 2015, Endocrine.

Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density

T. Sugimoto, M. Yamauchi, T. Yamaguchi, 2009, Osteoporosis International.

Role of Parathyroid Hormone in Bone Fragility of Postmenopausal Women with Vitamin D Insufficiency

T. Sugimoto, Toru Yamaguchi, M. Yamauchi, 2011, Calcified Tissue International.

Elcatonin is effective for lower back pain and the symptoms of gastroesophageal reflux disease in elderly osteoporotic patients with kyphosis

S. Yano, Y. Kinoshita, T. Sugimoto, 2011, Geriatrics & gerontology international.

Multiple vertebral fractures are associated with refractory reflux esophagitis in postmenopausal women

K. Chihara, T. Sugimoto, Toru Yamaguchi, 2004, Journal of Bone and Mineral Metabolism.

Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes

S. Yano, Ken-ichiro Tanaka, T. Sugimoto, 2013, Journal of Bone and Mineral Metabolism.

Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus

T. Sugimoto, Masahiro Yamamoto, M. Yamauchi, 2019, PloS one.

Acute suppurative thyroiditis caused by thyroid papillary carcinoma in the right thyroid lobe of a healthy woman

R. Maruyama, M. Notsu, T. Sugimoto, 2018, Thyroid Research.

Quantitative ultrasound and vertebral fractures in patients with type 2 diabetes

S. Yano, Eri Nitta, I. Kanazawa, 2011, Journal of Bone and Mineral Metabolism.

Papillary thyroid carcinoma is a risk factor for severe osteoporosis

M. Notsu, T. Sugimoto, M. Yamauchi, 2019, Journal of Bone and Mineral Metabolism.

Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus

S. Yano, I. Kanazawa, T. Sugimoto, 2007, Osteoporosis International.

The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failure.

S. Yano, I. Kanazawa, T. Sugimoto, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association Between Papillary Thyroid Carcinoma and Vertebral Fracture

M. Notsu, M. Yamauchi, K. Kanasaki, 2022, Hormone and Metabolic Research.

A case of aldosterone-producing adenoma with severe postoperative hyperkalemia.

S. Tanaka, M. Yamauchi, Y. Muramatsu, 1998, The Tohoku journal of experimental medicine.

A case of sarcoid reaction associated with papillary thyroid carcinoma.

M. Yamauchi, K. Kakudo, H. Koshiyama, 1997, Thyroid.

A Paranasal Tumor Associated With Tumor‐Induced Osteomalacia

T. Sugimoto, M. Yamauchi, A. Miyauchi, 2006, The Laryngoscope.

Association of n-3 Polyunsaturated Fatty Acid Intake with Bone Mineral Density in Postmenopausal Women

T. Sugimoto, Toru Yamaguchi, M. Yamauchi, 2013, Calcified Tissue International.

[Absolute risk for fracture and WHO guideline. Treatment of patients with secondary osteoporosis].

M. Yamauchi, 2007, Clinical calcium.

Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.

T. Sugimoto, Toru Yamaguchi, Masahiro Yamamoto, 2012, The Journal of clinical endocrinology and metabolism.

Association Between Papillary Thyroid Carcinoma and Vertebral Fracture

M. Notsu, M. Yamauchi, K. Kanasaki, 2022, Hormone and Metabolic Research.

Combination of Obesity with Hyperglycemia is a Risk Factor for the Presence of Vertebral Fractures in Type 2 Diabetic Men

S. Yano, I. Kanazawa, T. Sugimoto, 2008, Calcified Tissue International.

Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications

T. Sugimoto, Toru Yamaguchi, Masahiro Yamamoto, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Involvement of calcium-sensing receptor in osteoblastic differentiation of mouse MC3T3-E1 cells.

K. Chihara, T. Sugimoto, Toru Yamaguchi, 2005, American Journal of Physiology. Endocrinology and Metabolism.